Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
GLOBALFOUNDRIES enters the final stretch before its November 3 earnings date with a subtle but clear shift in tone: the call-heavy options positioning that defined last week's note has softened, short interest has ticked back up after a mid-week dip, and the stock dropped 3.4% on Tuesday to $46.70.
The options story is the most important update since the last note. A week ago, the put/call ratio had fallen to 0.90, more than 1.5 standard deviations below its 20-day average, signalling unusually strong call demand. That edge has narrowed. The ratio now stands at 0.91, still below the 20-day mean of 0.97, but the gap has compressed and the z-score has moved back toward neutral at roughly -0.93. The directional drift since early September remains intact: the PCR ran above 1.20 through August and has trended lower since. But the momentum of that shift has stalled this week, consistent with a market that is still leaning toward calls but no longer pushing that bet harder.
Short positioning has moved in the opposite direction. After falling nearly 9% across the week to a low around 6.9 million shares, short interest bounced 2.2% on Tuesday to 7.1 million shares, or 1.3% of free float. That level is too low to drive meaningful squeeze dynamics. What is worth noting is the one-month context: shorts have added roughly 34% from their early-September trough, climbing from around 5.2 million shares to the current level. The borrow market offers no friction to further building. Availability is deep at 707% of short interest, meaning there are roughly seven shares available to borrow for every one already shorted, well clear of any constraint. Cost to borrow has crept higher, up 17% on the week to 0.49%, and has nearly doubled over the past month. That is still a negligibly cheap borrow in absolute terms, but the direction is worth tracking as the earnings date closes in.
The Street remains largely on the fence, and recent analyst moves tell a story of fading enthusiasm rather than fresh conviction. Following Q1 results in early August, TD Cowen kept its Buy rating but cut its target from $85 to $75, and UBS trimmed from $61 to $55 while staying Neutral. Both cited execution concerns. Stifel initiated coverage in early September with a Buy and a $60 target. The consensus is Hold, with eight analysts there, three at Outperform or equivalent, and a mean target around $75. That implies roughly 60% upside from current levels, a gap that reflects the Street's uncertainty rather than confidence: the stock traded near $47 while targets cluster in the $55 to $85 range. The bull case centres on communication infrastructure and data centre revenue growing at high-30% year-on-year in 2026, alongside improving gross margin mix from SiPho and SiGe. Bears point to a -6% revenue CAGR across 2022 to 2025, operating margins that lagged a 25% guide by nearly ten percentage points in 2025, and ongoing pricing pressure at commodity process nodes. The EV/EBITDA multiple has eased to 8.4x, down about half a point over the past month, while the PE stands near 18.8x. Neither looks stretched relative to a foundry growing communications revenue at pace, but both depend heavily on the margin trajectory the November print will either confirm or complicate.
Ownership structure is worth a brief note. Mubadala, the Abu Dhabi sovereign fund, holds 72.8% of shares and trimmed its position by 23.5 million shares in Q2. FMR (Fidelity) holds 12.5% and added 4.5 million shares through July, filing a passive 13G/A in August lifting its disclosed stake from 11.5% to 12.7%. Neither is an activist filing. The insider register shows nothing materially interesting: recent sales are small, pre-planned (10b5-1), and dominated by the Chief Legal Officer disposing of 335 shares at a time on a mechanical schedule. Net insider value over 90 days is roughly -$937,000, but that is almost entirely from tax-withholding transactions coded as F rather than discretionary open-market sales, so it carries little signal.
Across the peer group, the week's price action has been broadly weak. DIOD fell 15.8% on the week, ALGM lost 13.2%, POWI dropped 12.5%, and NVTS shed 12.7%. GFS's 4% decline looks relatively contained by comparison, though that is a low bar in a sector that has clearly been under pressure. Whether that relative resilience reflects confidence in GFS's differentiated revenue mix or simply a lower-beta starting point is the question the November 3 print will need to answer.
With twenty days to the report, the note to watch is whether the PCR drift back toward neutral continues, and whether short interest adds further to the one-month buildup or reverses again as traders position around the print.
See the live data behind this article on ORTEX.
Open GFS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.